Intralesional PV-10 Chemoablation of Metastatic Melanoma
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety of intralesional (IL) PV-10 for the
treatment of metastatic melanoma. This study will also include a preliminary assessment of
response of treated and untreated lesions by clinical evaluation at follow-up of 12 to 24
weeks following IL PV-10 treatment.